Drugs / nafulizumab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04427475 | Jun 2020 → Dec 2021 | non-small cell lung carcinoma | Fudan University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | nafulizumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04427475 ↗ |